FAP and neoplasm: Further strategies such as FAP-CAR-T cell therapy and FAP-targeted oncolytic adenovirus promote a specific immune attack against FAP + CAFs, upregulate pro-inflammatory cytokines, and increase antigen presentation, T cell function, as well as trafficking, leading to enhanced anti-tumor efficacy [129–131].